
Sign up to save your podcasts
Or
This week the EU unveiled its plan to rein in big tech—the draft laws target the American giants, but European firms may not benefit much. Also, how a failed study has revealed a promising new gene-therapy treatment for blindness. And, which science stories were overlooked in a year dominated by covid-19? Kenneth Cukier hosts
Please subscribe to The Economist for full access to print, digital and audio editions:
www.economist.com/podcastoffer
Hosted on Acast. See acast.com/privacy for more information.
4.8
570570 ratings
This week the EU unveiled its plan to rein in big tech—the draft laws target the American giants, but European firms may not benefit much. Also, how a failed study has revealed a promising new gene-therapy treatment for blindness. And, which science stories were overlooked in a year dominated by covid-19? Kenneth Cukier hosts
Please subscribe to The Economist for full access to print, digital and audio editions:
www.economist.com/podcastoffer
Hosted on Acast. See acast.com/privacy for more information.
4,249 Listeners
525 Listeners
919 Listeners
365 Listeners
99 Listeners
221 Listeners
107 Listeners
2,520 Listeners
45 Listeners
1,076 Listeners
1,379 Listeners
138 Listeners
115 Listeners
101 Listeners
36 Listeners
889 Listeners
345 Listeners
497 Listeners
80 Listeners
68 Listeners
100 Listeners
101 Listeners
203 Listeners